All In Biotech

Drug Trial Radar · NCT06413420

SUNOSI® (Solriamfetol) Pregnancy Registry

SUNOSI® (Solriamfetol) Pregnancy Registry: An Observational Study on the Safety of Solriamfetol Exposure in Pregnant Women and Their Offspring

Last checked: Nov 20, 2026Latest source record: Oct 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

1,731

Planned (sponsor's estimate)

Start

Jul 31, 2019

Primary completion

Sep 2029

Study completion Sep 2029

Sponsor

Lead sponsor
Axsome Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
May 14, 2024

More drug trials from this sponsor

Design

Study type
Observational
FDA-regulated drug
Yes
Who can join
Female only
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The SUNOSI (solriamfetol) Pregnancy Registry is a US- and Canada-based prospective, observational study to evaluate the safety of solriamfetol exposure during pregnancy in women with a diagnosis of narcolepsy or obstructive sleep apnea (OSA).

Conditions

  • Narcolepsy
  • Obstructive Sleep Apnea
  • Pregnant Women and Their Offspring

Interventions

  • Sunosi (solriamfetol)Drug

    Exposure to at least 1 dose of solriamfetol at any time during pregnancy or in the relevant exposure window before conception.

  • Other prescription wake-promoting medications or stimulantsDrug

    Exposure to at least 1 dose of a prescription wake-promoting medication or stimulant at any time during pregnancy or in the relevant exposure window before conception.

  • No treatmentOther

    No treatment

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Long-term SafetyTime frame: Baseline up to 12 months after pregnancy outcome

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Evidera, a PPD business unit

    Morrisville, North Carolina · Recruiting

  • PPD, Inc.

    Wilmington, North Carolina · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.